Stephenson Harwood advised Novacyt on Yourgene Health takeover. Novacyt UK, a diagnostics company, has agreed to acquire UK-based genomic medicine firm Yourgene Health in a £16.7...
You must be a Standard 1 Year member to access this content.
Stephenson Harwood advised BenevolentAI on strategic collaboration with Merck. BenevolentAI has entered into a strategic collaboration with Merck. This collaboration will leverage BenevolentAI’s comprehensive AI platform...
You must be a Standard 1 Year member to access this content.
Stephenson Harwood advised Bicycle Therapeutics on radiotherapy deal with Bayer. Bayer and Bicycle Therapeutics plc have announced a strategic collaboration agreement to develop, manufacture, and commercialize...
You must be a Standard 1 Year member to access this content.
Stephenson Harwood LLP has advised Bicycle Therapeutics. Bicycle Therapeutics signed a strategic collaboration agreement with Novartis to discover and develop multiple targeted radioligand therapies in oncology....
You must be a Standard 1 Year member to access this content.
Stephenson Harwood LLP has advised AM-Pharma on the deal. AM-Pharma signed a €245 million exclusive license agreement deal with Kyowa Kirin, for the development and commercialisation...
You must be a Standard 1 Year member to access this content.
